Cerebrospinal fluid levels of biotin in people with MS significantly lower !

Interesting: it might be one reason that prompted the eventual start of the French trial..........Sarah 

Completed Stratton/Wheldon regime for aggressive secondary progressive MS in June 2007, after four years, three of which intermittent.   Still improving bit by bit and no relapses since finishing treatment.

This can be detected in sufferers at an early stage in the disease, before there is massive neurlogical damage when treatment should be instigated.  I wonder why it has been suppressed for so long (1999)?  Answers on a post card to Big Pharma Tongue Out

Could people at risk of MS be screened at an early stage and given preventative treatment?